ALBERTDAVDAlbert David Limited
Pharma · Drug Manufacturers - Specialty & Generic · NSE · as of 2026-10-26 (delayed ~30 min in market hours)
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.
Price & Volume
Loading chart…
Key Ratios
“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.
Active Pattern Signals
None of the 16 pattern scanners currently detects a setup on ALBERTDAVD — signals appear here automatically when one forms (checked on every data refresh). The Trade Plan on the right always provides stop-loss and target levels regardless.
The picture
- • Revenue growth: 43.6% YoY
- • Profit growth: 303.1% YoY
- • Debt/Equity: 0.08
- • Price vs SMA200: above
- • Golden cross setup: SMA50 above SMA200
- • 3-month return: +14.4%
Bull case
- • Revenue growth: 43.6% YoY
- • Profit growth: 303.1% YoY
- • Debt/Equity: 0.08
- • Price vs SMA200: above
Bear case
- • ROE: -0.4%
- • ROCE: -1.0%
- • MACD: bearish
- • Price vs EMA21: below
Key risks
- • Elevated volatility / drawdown profile — size positions accordingly
- • ROE: -0.4%
- • ROCE: -1.0%
Algorithmic analysis for research only — not SEBI-registered investment advice.
Trade Plan
Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹32.48). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.